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Abstract
Background: Advanced age is associated with immunosenescence as well as increased risk
for poor outcomes during episodes of community-acquired pneumonia (CAP). Data on neutrophil
function in hospitalized elderly patients with CAP is lacking. In this study we compared neutrophil
function in elderly and non-elderly hospitalized patients with CAP.
Methods: Prospective study of healthy controls (HC) and patients hospitalized with CAP nonelderly (NE-CAP) and elderly (E-CAP). Blood samples were obtained on the day of hospitalization.
The following neutrophil functional assays were performed: degranulation of secretory vesicles
(CD35), degranulation of specific granules (CD66b), phagocytosis, and hydrogen peroxide (H2 O2 )
production. The Mann-Whitney U-test was used to compare differences in neutrophil function.
Results: A total of 12 HC, 28 NE-CAP, and 12 E-CAP were evaluated. There were no significant differences between NE-CAP and E-CAP patients in regard to CD35 expression (p=0.465),
CD66b expression (p=0.601), phagocytosis (p=0.654), or H2 O2 production (p=0.541)
Conclusions: We failed to demonstrate any significant difference in neutrophil function in nonelderly versus elderly patients hospitalized with CAP in relation to membrane expression of CD35
and CD66b, phagocytosis, and respiratory burst. Abnormal neutrophil function is unlikely to be an
important component of the immunosenescence described in elderly patients with CAP.
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Background

Elderly patients with community-acquired pneumonia (CAP) are
at increased risk for poor clinical outcomes when compared to
non-elderly patients. Advanced age is an independent risk factor
for mortality present in several of the CAP severity scores 1 . Human aging is associated with a gradual decrease of immune function, defined as immunosenescence 2 . In the elderly, immunosenescence affects innate and adaptive immune responses. This
may explain the increased susceptibility of the elderly to develop
CAP, as well as the increased morbidity and mortality in these
patients 3 .
Neutrophils are the primary effector cells of the innate response
and are the first line of defense against bacteria multiplying in
the lung. During an episode of CAP, neutrophils recognize and
bind immunoglobulin G molecules and complement proteins that
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coat the surface of bacteria in the alveoli. After binding to bacteria, killing is achieved by phagocytosis, the fusion of phagosomes with intracellular secretory granules, followed by degranulation and respiratory burst 4–6 . Even though there is a significant
body of literature defining neutrophil function for several human
conditions, none of these critical neutrophil functions have been
characterized in patients with CAP.
Considering the importance of neutrophil function in the innate
immune response during an episode of CAP and the poor clinical
outcomes of CAP in the elderly, we hypothesized that decreased
neutrophil function may be an important contributor to the immunosenescence described in the elderly. To test this hypothesis
we compared neutrophil function in elderly and non-elderly hospitalized patients with CAP.
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Methods
Study design and participants

This was a prospective observational study of hospitalized patients with CAP as well as healthy controls. Patients hospitalized
with CAP were enrolled at the University of Louisville Hospital

Table 1 Baseline characteristics of hospitalized patients with community-acquired pneumonia

Variable
Demographics
Age, median (IQR)
Male Gender
Past Medical History
Smoking
Neurologic Diseases
Cerebrovascular Diseases
CHF
COPD
Diabetes mellitus
HIV
Acute Renal Diseases
Chronic Renal Diseases
Hepatic Diseases
Neoplastic Diseases
Hyperlipidemia
Statin Therapy
Immunosuppression
Vaccination History
Previous Influenza vaccine
Previous Pneumococcal vaccine
Clinical, Laboratory and Radiological Findings
Alter Mental Status
Pleural Effusion
ICU Admission
Fever (Temp ≥ 100◦ F)
White Blood Cell Count, Median (IQR)
Healthcare-Associated Pneumonia (HCAP)
Pneumonia Severity Index (PSI) ≥ 4
S. pneumoniae
Macrolide Therapy
Early Time to Clinical Stability (< 3 days)

and the Robley Rex Veterans Affairs Medical Center of Louisville
from March 2011 to January 2012. The University of Louisville
Human Subjects Program Protection Office and the Robley Rex
Veterans Affairs Medical Center Institutional Review Boards approved this study prior to any data collection (Approvals #:
07.0182 and 0009, respectively).
2.2

Definition of CAP in the elderly

A patient was considered to have CAP if there was evidence of
a new pulmonary infiltrate at chest radiograph at time of hospitalization plus at least one of the following criteria: 1) new
or increased cough; 2) fever (>100◦ F) or hypothermia (<96◦ F);
3) changes in white blood cell count (leukocytosis, left shift, or
leukopenia). A patient was defined as elderly if his/her age was
≥65 years.
2.3

Definition of healthy controls

Healthy controls were defined as blood donors meeting the following criteria: 1) negative history for chronic medical conditions, 2) not currently pregnant, 3) asymptomatic during the
week previous to blood collection, and 4) not currently taking
prescription or over-the-counter medication. Laboratory methods: Blood samples were obtained from CAP patients on the day
of hospital admission. Venous blood was collected using sodium
citrate Vacutainer R tubes. Following centrifugation at 300 × g
for 10 min, the plasma was separated by aspiration, aliquoted
and stored frozen at -80◦ C until assayed. The same process was
followed for healthy control blood samples.
2.4

Neutrophil functional assays

Degranulation of secretory vesicles (CD35) and specific granules (CD66b) was determined by measuring plasma membrane

Elderly (≥ 65)
n = 12
n = 28

Non-Elderly (<65)
n (%)
n (%)

78.5 (9)
11 (92)

53 (9.5)
23 (82)

0.648

0 (0)
1 (8)
4 (33)
7 (58)
7 (58)
7 (58)
0 (0)
2 (17)
3 (25)
0 (0)
3 (25)
9 (75)
5 (42)
3 (25)

16 (57)
2 (7)
2 (7)
6 (22)
7 (26)
5 (19)
3 (11)
1 (4)
2 (7)
2 (7)
1 (4)
6 (21)
6 (21)
4 (14)

0.001
1
0.06
0.062
0.075
0.023
0.541
0.229
0.159
1
0.078
0.003
0.254
0.41

6 (50)
8 (67)

4 (14)
5 (18)

0.041
0.008

2 (17)
4 (33)
5 (42)
5 (41.7)
14.0 (5.4)
3 (25)
10 (83)
4 (33)
4 (33)
7 (58)

1 (4)
8 (29)
8 (29)
16 (57.1)
11.4 (5.8)
7 (25)
12 (43)
5 (18)
10 (36)
19 (68)

0.209
1
0.476
0.580
0.092
1
0.035
0.411
1
0.72

p-value

expression, using flow cytometry. After incubation of whole
blood with and without formyl-methionyl-leucyl phenylalanine
for 5 min at 37◦ C, an ice-cold solution containing antibody
FITC-conjugated monoclonal anti-CD35 or FITC-conjugated monoclonal anti-CD66b were added and the samples immediately
placed at room temperature in the dark for 30 min. FITCconjugated mouse IgG1 and PE-conjugated mouse IgG1 were
used as an isotype controls respectively. At the end of the incubation time the samples were mixed with lysis buffer, and incubated for 5 min at room temperature (RT), after which they
were washed two times with 0.1% sodium azide and then resuspended in 1% paraformaldehyde, before being analyzed for fluorescence intensity by flow cytometry (mean channel fluorescence)
on a FACSCalibur instrument (Becton Dickinson, Franklin Lakes,
NJ). To measure phagocytosis and hydrogen peroxide production in phagosomes, whole blood samples were incubated with
dichlorofluorescin diacetate for 10 min at 37◦ C. Fifty microliters
of whole blood was sampled before, and 10 min later, the addition
of 50 ml of opsonized, propidium iodide-labeled Staphylococcus
aureus (final concentration 108 bacteria/ml). At the end of the
incubation time, samples were mixed with lysis buffer, and allow
to sit for 5 min at RT. The samples were then washed twice with
0.1% sodium azide, resuspended in 1% paraformaldehyde, and
analyzed for fluorescence intensity by flow cytometry, excluding
mononuclear cells.
2.5

Study groups and statistical analysis

Neutrophil function was evaluated for healthy controls (study
group 1), hospitalized non-elderly patients with CAP (study group
2), and hospitalized elderly patients with CAP (study group 3).
The Mann-Whitney U-test was used to compare differences in
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Fig. 1 Neutrophils plasma membrane expression of CD35 under baseline conditions and after stimulation with formyl-methionyl-leucyl phenylalanine
(fmlf) for each of the study groups.

Fig. 2 Neutrophils plasma membrane expression of CD66b under baseline conditions and after stimulation with formyl-methionyl-leucyl phenylalanine
(fmlf) for each study group.

neutrophil function between healthy controls (group 1) and hospitalized patients with CAP (groups 2 and 3 combined) as well as
between non-elderly (group 2) and elderly (group 3) hospitalized
patients with CAP.

3

Results

Neutrophil function was evaluated in 52 study participants, 12
healthy controls, 28 non-elderly hospitalized patients with CAP,
and 12 elderly patients hospitalized with CAP. The baseline characteristics of non-elderly and elderly hospitalized patients with
CAP are depicted in Table 1.
The neutrophil plasma membrane expression of CD35 under
baseline conditions and after stimulation with formyl-methionylleucyl phenylalanine is depicted in Figure 1. A statistically significant increase in CD35 expression was seen for all CAP patients when compared to healthy donors under unstimulated and
stimulated conditions (p<0.001 each). There were no significant
differences in CD35 expression for non-elderly versus elderly patients with CAP under basal conditions (p=0.465) or after stimulation (p=0.846).
The plasma membrane expression of CD66b in neutrophils under
14 |
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baseline conditions and after stimulation with formyl-methionylleucyl phenylalanine is depicted in Figure 2. There were no differences between CD66b expression for all CAP patients versus
healthy donors in unstimulated conditions (p=0.080), however a
statistically significant increase in CD66b expression was seen for
all CAP patients when compared to healthy donors under stimulated conditions (p<0.001). There were no significant differences in CD66b expression for non-elderly versus elderly patients
with CAP under basal conditions (p=0.601) or after stimulation
(p=0.629).
The neutrophil phagocytosis of opsonized propidium iodidelabeled Staphylococcus aureus for healthy donors, non-elderly hospitalized patients with CAP, and elderly hospitalized patients with
CAP are depicted in Figure 3. No statistically significant differences were demonstrated among the study groups (CAP vs
healthy p=0.288; CAP non-elderly vs elderly p=0.654).
The neutrophil hydrogen peroxide production in phagosomes for
healthy donors, non-elderly hospitalized patients with CAP, and
elderly hospitalized patients with CAP are depicted in Figure 4. A
statistically significant increase in hydrogen peroxide production
was demonstrated for CAP patients when compared to healthy

Fig. 3 Neutrophils phagocytosis of opsonized propidium iodide-labeled Staphylococcus aureus for each study group.

Fig. 4 Neutrophils hydrogen peroxide production in phagosomes for each of the study groups.

donors (p<0.001). There were no statistically significant differences in hydrogen peroxide production in non-elderly versus elderly hospitalized patients with CAP (p=0.541).

4

Discussion

In this study we failed to demonstrate any significant difference
in neutrophil function in non-elderly versus elderly patients hospitalized with CAP in relation to membrane expression of CD35
and CD66b, phagocytosis, and respiratory burst.
Prior studies have documented that neutrophil precursors in the
bone marrow, as well as the number of neutrophils present in
the systemic circulation are not different in non-elderly and elderly adults 7,8 . Neutrophil chemotaxis is important to bring neutrophils from the pulmonary circulation into the alveoli. The
process of neutrophil chemotaxis has been shown to be unaffected by age 9 . Once neutrophils migrate to the alveoli, the initial recognition and binding of opsonized bacteria is mediated by
neutrophil surface receptors, including the complement receptor
CR1 or CD35 10 . Degranulation of secretory vesicles and degranulation of specific granules are important neutrophil functions that
are associated with membrane expression of CD35 and CD66b 10 .
In our study, the expression of these membrane markers was sim-

ilar in circulating neutrophils of non-elderly and elderly hospitalized patients with CAP. However, these two groups of CAP patients have a significant increase in the membrane markers CD35
and CD66b when compared to healthy controls after stimulation
with formyl-methionyl-leucyl phenylalanine. This suggests that
after maturation and release from the bone marrow, neutrophils
of hospitalized patients with CAP are already primed in the peripheral circulation, and are ready to express membrane receptors
once they arrive to the lung.
In our study we use opsonized propidium iodide-labeled Staphylococcus aureus as a marker of phagocytosis. These results indicate
that the phagocytic ability of circulating neutrophils against S. aureus is not affected by age. Our data suggests that the phagocytic
ability of circulating neutrophils in hospitalized patients with CAP
is similar to that of healthy controls. It has been suggested that
neutrophil phagocytosis may be pathogen specific. The fact that
we found normal phagocytosis of S. aureus and a prior study indicated a reduced neutrophil phagocytosis of E. coli in elderly
donors supports this concept 4 .
After phagocytosis, stimulation of the respiratory burst with rapid
release of reactive oxygen species is a crucial step for bacterial
killing. In our study, we used production of hydrogen peroxide in
ULJRI 2017 Vol 1, (1)
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phagosomes as a marker of respiratory burst. We demonstrated
that the level of phagocytosis stimulated respiratory burst is not
decreased in non-elderly patients when compared to elderly patients with CAP. Our data is concordant with prior reports indicating that superoxide generation is not affected in neutrophils
obtained from elderly donors 4 .
The current study has several limitations. First, we only evaluated a limited number of hospitalized patients with CAP, which
limits generalizability of our results. Second, we compared neutrophil function only in circulating neutrophils, but the activity
of circulating neutrophils may not be a complete reflection of the
activity of neutrophils once they migrate to the alveoli. Third, we
evaluated the neutrophil membrane expression of two primary
molecules, CD35 and CD66b, but neutrophils in elderly patients
with CAP may fail to express other membrane receptors not evaluated in our study. Fourth, other neutrophil functions that may be
associated with poor clinical outcomes, such as type of cell death,
were not evaluated. Neutrophil death may occur in the form of
apoptosis, netosis, pyroptosis, or necrosis 11 . Apoptosis and netosis are non-inflammatory programmed cell death types associated
to beneficial effects. On the other hand, pyroptosis and necrosis
are associated with increased inflammation that, in turn, may favor tissue damage and worse clinical outcomes 12 .
Some aspects of neutrophil function in patients with CAP can be
evaluated in neutrophils obtained from bronchoalveolar lavage
samples as well as sputum samples. Our group recently reported
an evaluation of neutrophil apoptosis from neutrophils obtained
from sputum samples in a hospitalized patient with influenza
CAP 13 . Future studies using these respiratory samples may give
us a better understanding of neutrophil function at the alveolar
level in hospitalized patients with CAP.
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Beyond the pilot design, our study limitations include the assessment of neutrophil functions from the patient hospital admission
day only and this assessment was in-vitro only.

10

In conclusion, this study demonstrates that some of the most critical neutrophil functions in patients with CAP are not decreased in
the elderly, suggesting that abnormal neutrophil function is unlikely to be an important component of the immunosenescence
described in elderly patients with CAP.
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